Axe Compute Inc
Axe Compute Inc is a biotechnology company focused on healthcare diagnostics, primarily generating revenue through the development and commercialization of diagnostic solutions.
Business. Axe Compute Inc (AGPU.O) is a biotechnology and medical research company focused on healthcare diagnostics. The firm operates within the pharmaceuticals and medical research sector, generating revenue through product sales. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the NASDAQ exchange.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Axe Compute Inc (AGPU.O) is a biotechnology and medical research company focused on healthcare diagnostics. The firm operates within the pharmaceuticals and medical research sector, generating revenue through product sales. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the NASDAQ exchange.
Axe Compute Inc exhibits a highly leveraged equity structure, with a market price of $5.55 per share and a market capitalization of $30.74 million. The company's price-to-book ratio of 0.64 suggests that the market values the company at a discount to its book value, while the price-to-tangible-book ratio is identical, indicating no intangible asset premium. The enterprise value to revenue ratio of 246.26 is significantly higher than typical industry benchmarks, reflecting a high valuation relative to its current revenue base.
Profitability metrics for Axe Compute Inc are deeply negative, with a return on equity of -4.885% and a return on assets of -4.4073%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income of -$180.92 million and net income of -$233.10 million further underscore the company's financial distress. The gross profit margin of 42.03% is relatively high, but this is offset by substantial operating and non-operating expenses.
Geographically and segment-wise, Axe Compute Inc's revenue concentration is not explicitly detailed in the available data. However, the company's operations are primarily focused on healthcare diagnostics, with no significant diversification across business lines or regions. This lack of diversification could expose the company to sector-specific risks, particularly in the biotechnology and medical research fields.
The company's growth trajectory is concerning, with a significant decline in operating cash flow of -$9.96 million and a free cash flow of -$265.35 million. The capital expenditure of -$32.62 million indicates a heavy investment in infrastructure, which may not be yielding positive returns at this time. The outlook for the current fiscal year is negative, with no clear signs of improvement in the near term.
Risk factors for Axe Compute Inc include a medium liquidity risk, as indicated by the current ratio of 10.02, which suggests the company has sufficient current assets to cover its current liabilities. However, the company's net cash position is negative after accounting for total debt, which could pose a liquidity challenge. The dilution risk is currently low, but the company's financial performance and capital structure may change this outlook in the future.
Recent events and filings indicate that Axe Compute Inc is facing significant financial challenges, with a last actual EPS of -$34.80 and a last actual revenue of $1.624 million. These figures highlight the company's struggle to generate positive earnings and revenue, which could impact investor confidence and future funding opportunities.
- Axe Compute Inc is operating at a significant loss, with a net income of -$233.10 million and a return on equity of -4.885%.
- The company's market valuation is high relative to its revenue, with an enterprise value to revenue ratio of 246.26.
- The company's liquidity position is medium, with a current ratio of 10.02, but it has a negative net cash position after accounting for total debt.
- Axe Compute Inc's growth trajectory is negative, with a substantial decline in operating and free cash flow.
- The company's financial performance and capital structure may increase dilution risk in the future.
- Recent financial filings indicate a significant decline in earnings and revenue, which could impact investor confidence.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Co-Chief Financial Officer · Non-Qualified Stock Options → Common StockAcquired 225 000 @ $3,51grant · 2026-04-16
- President · Non-Qualified Stock Options → Common StockAcquired 300 000 @ $1,62grant · 2026-04-01
- Director, CEO and Director · Non-Qualified Stock Options → Common StockAcquired 500 000 @ $2,44grant · 2026-02-09
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Axe Compute Inc Market data — financials · 2026-05-27
- Axe Compute Inc Market data — analyst estimates · 2026-05-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockOther 11 250 @ $6,61$74K · 2026-05-29
- Director · Common StockOther 3 750 @ $6,61$25K · 2026-05-28
- Co-Chief Financial Officer · Common StockOther 9 389 · 2026-05-14
- Director · Common StockOther 6 782 · 2026-04-20
- Director · Common StockOther 5 144 · 2026-04-20
- Director · Common StockOther 14 082 · 2026-04-20
- Director · Common StockOther 9 419 · 2026-04-20
- Director · Common StockOther 5 663 · 2026-04-20
- Director · Common StockOther 4 197 · 2026-03-06
- Director · Common StockOther 1 166 · 2026-03-06
- Director, Chief Executive Officer · Common StockOther 6 758 @ $2,59$18K · 2026-02-05
- Director, Chief Executive Officer · Common StockOther 20 000 · 2025-12-10
- Director, Chief Executive Officer · Common StockOther 2 373 @ $5,90$14K · 2025-11-28
- Director · Common StockOther 64 680 · 2025-09-09
- Director · Common StockOther 64 680 · 2025-09-09
- Director · Common StockOther 64 680 · 2025-09-09
- Director · Common StockOther 64 680 · 2025-09-09
- Director · Common StockOther 64 680 · 2025-09-09
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Return on equity (FY 2025-12-31): -488.5%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -1,740.6%Derived (calculated)
- Return on assets (FY 2025-12-31): -440.7%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -100.0%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): -7.2%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.11xDerived (calculated)
- Current ratio (FY 2025-12-31): 10.02xDerived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -1,655.8%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 1,663.7%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -0.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 61.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 23,651.1%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 963.6%Derived (calculated)
- Operating income (annual): USD -180.92MSEC XBRL filing
- Current liabilities (annual): USD 4.27MSEC XBRL filing
- Total assets (annual): USD 52.89MSEC XBRL filing
- Total liabilities (annual): USD 5.17MSEC XBRL filing
- Net income (annual): USD -233.1MSEC XBRL filing
- Cost of revenue (annual): USD 72.62KSEC XBRL filing
- Capex (annual): USD 0SEC XBRL filing
- Shareholders' equity (annual): USD 47.72MSEC XBRL filing
- Cash & equivalents (annual): USD 10.79MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -13SEC XBRL filing
- Shares outstanding (annual): 4.08MSEC XBRL filing